Clinical Trial: Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07801859) titled 'Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH' on Aug. 17.

Brief Summary: To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level and re-ascent from sea level to 2850m on heart rate variability and other hemodynamic parameters in patients with pulmonary arterial hypertension PAH, who live permanently >2600m.

Study Start Date: Sept. 25

Study Type: INTERVENTIONAL

Condition: High Altitude Effects High Altitude Pulmonary Vascular Disease Pulmonary Arterial Hypertens...